The early-stage fund, Faad Network has invested in Larkai Healthcare Pvt. Ltd., a global medtech company that provides advanced, affordable, and accessible healthcare solutions.  

Larkai Healthcare secured an investment of $500,000 for the seed funding round from FAAD Network, QI Ventures, RTAF, and additional government grants, the investment added in a release. 

The healthcare start-up aims to develop the next generation of technology in healthcare and to fortify and amplify its sales verticals through strategic investments. 

Larkai uses cutting-edge algorithms and artificial intelligence to ensure accurate reports that can detect crucial ailments thereby helping in treatments with precision.   

"Investing in Larkai stands as a testament to our unwavering dedication to spearheading transformative tech innovation," said Dr Dinesh Singh, co-founder and director of FAAD Network. "Their groundbreaking AI-infused approach to revolutionising healthcare resonates deeply with our mission of catalyzing impactful change in the realm of technology ventures." 

Founded in 2020, by Pritam Dhalla and Abhilash Chakraverty, Larkai Healthcare bridges the gap between diagnosis and treatment with its commitment to deliver instant and early diagnosis with accuracy through its advanced AI technology The company aims to deploy AI in healthcare, making it accessible to anyone, anytime, and anywhere. 

Abhilash Chakraverty, co-founder and director of Larkai Healthcare, said, "Seizing this investment, we are poised to bridge the gap between diagnosis and treatment, leveraging our global footprint and robust intellectual assets. This fuels our vision for healthcare—transcending borders, transforming lives, and setting new benchmarks in accessibility and innovation." 

Recently FAAD has received approval from the Securities and Exchange Board of India (SEBI) for a category 1 Rs 300 crore Alternative Investment Fund (AIF).